Breast implant firm Sientra has prevailed in a lawsuit brought by competitor Mentor Worldwide over allegations that Sientra engaged in unfair business tactics by hiring more than a dozen of Mentor’s sales staff shortly after Sientra’s implants were approved in 2012. The suit stems from a heated race among implant makers to bring new teardrop-shaped Read More →
By Stephen Nellis / Friday, July 26th, 2013 / Technology, Top Stories / Comments Off on Mentor inks deal and gets FDA approval for new implants
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Stephen Nellis / Thursday, January 17th, 2013 / Latest news, Technology / Comments Off on Sientra’s CEO tells of startup’s struggle and success
In 2007, it seemed like an simple path to success: Sientra, a startup led by breast implant industry veterans, would acquire a portfolio of silicone implants, raise money and seek approval from the U.S. Food and Drug Administration to become the first new player in the industry in two decades. Between then and now, however, Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Backed with $151 million in capital, Santa Barbara-based breast implant maker Sientra is preparing for a flurry of hiring to bring its products to market. In early March, Sientra received the first FDA approval in several decades for new silicone-based implants for the U.S. market. Two weeks later, the firm said it closed a $65 Read More →
Sientra, the Santa Barbara breast implant company that recently received the first FDA approval in several decades for new implants for the U.S. market, has closed a $65 million funding round, bringing its total capital raised to $151 million. The lead investor on the private equity deal was London-based life sciences fund Abingworth. Sientra’s existing Read More →
By Stephen Nellis / Friday, March 23rd, 2012 / Technology, Top Stories / Comments Off on A new player in Silicone Alley: Sientra enters breast implant industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.